Champalimaud Foundation - Academic Profile

Publications

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid , Javier Cortés , Lajos Pusztai +18 more

Among patients with early triple-negative breast cancer, the percentage with a pathological complete response was significantly higher among those who received pembrolizumab plu...

2020 New England Journal of Medicine 2718 citations

Breast cancer

Nadia Harbeck , Frédérique Penault‐Llorca , Javier Cortés +6 more

2019 Nature Reviews Disease Primers 2678 citations

Current and future burden of breast cancer: Global statistics for 2020 and 2040

Melina Arnold , Eileen Morgan , Harriet Rumgay +8 more

2022 The Breast 2669 citations

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fátima Cardoso , S. Kyriakides , Shinji Ohno +5 more

2019 Annals of Oncology 2079 citations

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)

Jean‐Pascal Lefaucheur , André Alemán , Chris Baeken +28 more

2020 Clinical Neurophysiology 1986 citations

Affiliated Researchers

Fátima Cardoso

Champalimaud Foundation

Institution Info

Type: facility
Country: PT
Publications: 5
Citations: 12,130

External Links

Identifiers

ROR: https://ror.org/03g001n57